2007年
Plasmin-assisted vitrectomy for management of proliferative membrane in proliferative diabetic retinopathy: a pilot study.
Hirata A, Takano A, Inomata Y, Yonemura N, Sagara N, Tanihara H. Retina. 2007
ーーーーーーーーーー
Pitavastatin: protection against neuronal retinal damage induced by ischemia-reperfusion injury in rats.
Kawaji T, Inomata Y, Takano A, Sagara N, Inatani M, Fukushima M,Tanihara H, Honjo M.
Curr Eye Res. 2007
ーーーーーーーーーー
Effect of pitavastatin on experimental choroidal neovascularization in rats.
Sagara N, Kawaji T, Takano A, Inomata Y, Inatani M, Fukushima M,Tanihara H. Exp Eye Res. 2007
2006年
Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
Ikema K, Matsumoto K, Inomata Y, Komohara Y, Miyajima S, Takeya M,Tanihara H. Exp Eye Res. 2006
ーーーーーーーーーー
Thioredoxin inhibits NMDA-induced neurotoxicity in the rat retina.
Inomata Y, Nakamura H, Tanito M, Teratani A, Kawaji T, Kondo N, Yodoi J, Tanihara H. J Neurochem. 2006
ーーーーーーーーーー
Posterior vitreous detachment induced by nattokinase (subtilisin NAT): a novel enzyme for pharmacologic vitreolysis.
Takano A, Hirata A, Ogasawara K, Sagara N, Inomata Y, Kawaji T,Tanihara H. Invest Ophthalmol Vis Sci. 2006
ーーーーーーーーーー
NMDA-induced retinal injury is mediated by an endoplasmic reticulum stress-related protein, CHOP/GADD153.
Awai M, Koga T, Inomata Y, Oyadomari S, Gotoh T, Mori M, Tanihara H. J Neurochem. 2006
2005年
Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous.
Takano A, Hirata A, Inomata Y, Kawaji T, Nakagawa K, Nagata S, Tanihara H. Am J Ophthalmol. 2005
ーーーーーーーーーー
Trans-tenon retrobulbar triamcinolone injection for macular edema associated with branch retinal vein occlusion remaining after vitrectomy.
Kawaji T, Hirata A, Awai N, Takano A, Inomata Y, Fukushima M, Tanihara H. Am J Ophthalmol. 2005
ーーーーーーーーーー
Transthyretin synthesis in rabbit ciliary pigment epithelium.
Kawaji T, Ando Y, Nakamura M, Yamamoto K, Ando E, Takano A, Inomata Y, Hirata A, Tanihara H. Exp Eye Res. 2005
ーーーーーーーーーー
Expression of a chondroitin sulfate proteoglycan, versican (PG-M), during development of rat cornea.
Koga T, Inatani M, Hirata A, Inomata Y, Zako M, Kimata K, Oohira A, Gotoh T, Mori M, Tanihara H. Curr Eye Res. 2005
ーーーーーーーーーー
Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases.
Yoneda S, Hara H, Hirata A, Fukushima M, Inomata Y, Tanihara H. Jpn J Ophthalmol. 2005
2004年
Elevated erythropoietin in vitreous with ischemic retinal diseases.
Inomata Y, Hirata A, Takahashi E, Kawaji T, Fukushima M, Tanihara H. Neuroreport. 2004
ーーーーーーーーーー
Morphological damage in rabbit retina caused by subretinal injection of indocyanine green.
Kawaji T, Hirata A, Inomata Y, Koga T, Tanihara H. Graefes Arch Clin Exp Ophthalmol. 2004
2003年
Expression of glycosaminoglycans during development of the rat retina.
Koga T, Inatani M, Hirata A, Inomata Y, Oohira A, Gotoh T, Mori M,Tanihara H. Curr Eye Res. 2003
ーーーーーーーーーー
Lens epithelium-derived growth factor: neuroprotection on rat retinal damage induced by N-methyl-D-aspartate.
Inomata Y, Hirata A, Koga T, Kimura A, Singh DP, Shinohara T,Tanihara H. Brain Res. 2003
ーーーーーーーーーー
Persistent subretinal indocyanine green induces retinal pigment epithelium atrophy.
Hirata A, Inomata Y, Kawaji T, Tanihara H. Am J Ophthalmol. 2003
ーーーーーーーーーー
Neuroprotective effects of interleukin-6 on NMDA-induced rat retinal damage. Inomata Y, Hirata A, Yonemura N, Koga T, Kido N, Tanihara H. Biochem Biophys Res Commun. 2003
